Hepatic artery infusion chemotherapy combined with apatinib and toripalimab in advanced hepatocellular carcinoma: Real-world data from a single center.

被引：4
|
作者：
Gu, Yang-Kui
Zhang, Tian-Qi
Huang, Zi-Lin
Geng, Zhi-Jun
Chen, Chen
Li, Fu-Gui
Xu, Li
Sun, Jian
Li, Jibin
Huang, Zhi-Mei
Shen, Lujun
机构：
[1] Sun Yat Sen Univ, Collaborat Innovat Ctr Canc Med, Dept Minimally Invas Intervent Radiol, State Key Lab Oncol South China,Canc Ctr, Guangzhou, Peoples R China
[2] Sun Yat Sen Univ, Collaborat Innovat Ctr Canc Med, Dept Radiol, State Key Lab Oncol South China,Canc Ctr, Guangzhou, Peoples R China
[3] Jizhong Energy Fengfeng Grp Hosp, Dept Oncol, Handan, Peoples R China
[4] First Naval Hosp Southern Theater Command, Dept Oncol, Zhanjiang, Peoples R China
[5] Sun Yat Sen Univ, Dept Liver Surg, Canc Ctr, Guangzhou, Peoples R China
[6] Sun Yat Sen Univ, Canc Ctr, Guangzhou, Peoples R China
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2020年 / 38卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e16602
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Hepatic arterial infusion chemotherapy combined with immune checkpoint inhibitors and molecular targeted therapies for advanced infiltrative hepatocellular carcinoma: a single-center experience
    Wang, Zizhuo
    Song, Songlin
    Zhang, Lijie
    Yang, Tingting
    Yao, Wei
    Liang, Bin
    FRONTIERS IN IMMUNOLOGY, 2025, 15
  • [32] The role of targeted therapy (TKI) in the treatment of advanced hepatocellular carcinoma (aHCC) in the era of immunotherapy: Real-world data using AI analytics from an academic medical center.
    Wong, Rachel Su Jen
    Wu, Jiaxuan
    Leen, Alisha Joan
    Tey, Glenn Jin Chong
    Asokumaran, Yugarajah
    Chan, Gloria
    Siddappan, Chidambaram
    Jeyasekharan, Anand Devaprasath
    Chee, Cheng Ean
    Yong, Wei-Peng
    Ngiam, Kee Yuan
    Sundar, Raghav
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [33] Hepatic artery infusion chemotherapy (HAIC) combined with camrelizumab and apatinib as conversion therapy for initial unresectable hepatocellular carcinoma (HCC): A prospective, single-arm phase II trial
    Zhou, X.
    Zhu, H.
    Gao, H.
    Niu, Z.
    Liu, M.
    Wang, H.
    Kong, X.
    Ma, C.
    Yang, F.
    Hao, Y.
    Zhang, S.
    Lu, J.
    ANNALS OF ONCOLOGY, 2024, 35 : S1489 - S1489
  • [34] Hepatic Arterial Infusion Chemotherapy Combined with Lenvatinib Plus Humanized Programmed Death Receptor-1 in Patients with High-Risk Advanced Hepatocellular Carcinoma: A Real-World Study
    Chang, Xu
    Wu, Huiyong
    Ning, Shangkun
    Li, Xinge
    Xie, Yinfa
    Shao, Wenbo
    Yu, Jinming
    JOURNAL OF HEPATOCELLULAR CARCINOMA, 2023, 10 : 1497 - 1509
  • [35] Hepatic Arterial Infusion Chemotherapy Followed by Lipiodol Infusion for Advanced Hepatocellular Carcinoma with Portal Vein Tumor Thrombus: A Single-Center Experience
    Chen, Kuan-Ting
    Tsai, Kun-Feng
    Leung, Henry W. C.
    Chan, Agnes L. F.
    Wang, Shyh-Yau
    Liang, Huei-Lung
    Tang, Sheng-Yeh
    Chou, Chu-Kuang
    Chen, Hsin-Yu
    Chan, Shan-Ho
    Li, Ming-Feng
    MEDICINA-LITHUANIA, 2021, 57 (08):
  • [36] Immunotherapy for advanced hepatocellular carcinoma: From clinical trials to real-world data and future advances
    Rallis, Kathrine S.
    Makrakis, Dimitrios
    Ziogas, Ioannis A.
    Tsoulfas, Georgios
    WORLD JOURNAL OF CLINICAL ONCOLOGY, 2022, 13 (06): : 448 - 472
  • [37] A real-world experience of hepatic arterial infusion chemotherapy combined with tislelizumab and lenvatinib for unresectable hepatocellular carcinoma with type IV portal vein tumor thrombus.
    Li, Xiaowei
    Cao, Kunkun
    Fu, Zhigang
    Zhong, Jiaming
    Liu, Li
    Chen, Xiaoxia
    Ding, Ning
    Zhang, Xiaoli
    Qu, Zengqiang
    Zhai, Jian
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [38] Real-world data on nivolumab treatment in Asian patients with advanced hepatocellular carcinoma
    Yoon, S. E.
    Hur, J. Y.
    Lee, K. K.
    Lee, S. J.
    Lee, J.
    Paik, S. W.
    Lim, H. Y.
    ANNALS OF ONCOLOGY, 2018, 29
  • [39] Efficacy of apatinib 250 mg combined with chemotherapy in patients with pretreated advanced breast cancer in a real-world setting
    Zhang, Ruyan
    Chen, Yifei
    Liu, Xiaoran
    Gui, Xinyu
    Zhu, Anjie
    Jiang, Hanfang
    Shao, Bin
    Liang, Xu
    Yan, Ying
    Zhang, Jiayang
    Song, Guohong
    Li, Huiping
    FRONTIERS IN ONCOLOGY, 2023, 13
  • [40] Hepatic artery infusion chemotherapy (HAIC) combined with apatinib and camrelizumab for hepatocellular carcinoma (HCC) in BCLC stage C: A prospective, single-arm, phase II trial (TRIPLET study)
    Zhang, T-Q.
    Zuo, M-X.
    Geng, Z-J.
    Huang, Z-L.
    Li, J-B.
    Wu, P-H.
    Gu, Y-K.
    ANNALS OF ONCOLOGY, 2021, 32 : S825 - S825
12345